{
    "eid": "2-s2.0-85063954518",
    "title": "A new schizophrenia model: Immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuroscience (all)",
            "@code": "2800",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Cytokines",
        "Deficit schizophrenia",
        "Immune",
        "Inflammation",
        "Kynurenine",
        "Oxidative stress"
    ],
    "authors": [
        "Sunee Sirivichayakul",
        "Buranee Kanchanatawan",
        "Supaksorn Thika",
        "Andr\u00e9 F. Carvalho",
        "Michael Maes"
    ],
    "citedby-count": 31,
    "ref-count": 76,
    "ref-list": [
        "In Schizophrenia, depression, anxiety, and physiosomatic symptoms are strongly related to psychotic symptoms and excitation, impairments in episodic memory, and increased production of neurotoxic tryptophan catabolites: A multivariate and machine learning study",
        "The two-syndrome concept: Origins and current status",
        "Depressive and anxiety symptoms in patients with Schizophrenia and schizophreniform disorder",
        "Secondary negative symptoms-A review of mechanisms, assessment and treatment",
        "Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in Schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit Schizophrenia",
        "Towards a new classification of stable phase Schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis",
        "The schedule for the deficit syndrome: An instrument for research in Schizophrenia",
        "Deficit, but not nondeficit, Schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (Trycat) pathway with highly specific increases in IGA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "Deficit Schizophrenia is characterized by defects in igm-mediated responses to tryptophan catabolites (TRYCATs): A paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived trycat pathway activation",
        "The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "Immune-inflammatory markers in Schizophrenia: Comparison to normal controls and effects of clozapine",
        "Immune-inflammatory markers in Schizophrenia: Comparison to normal controls and effects of clozapine",
        "Acute phase proteins in Schizophrenia, mania and major depression: Modulation by psy-chotropic drugs",
        "Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis",
        "High predictive value of immune-inflammatory biomarkers for Schizophrenia diagnosis and association with treatment resistance",
        "Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic na\u00efve first episode psychosis",
        "Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression",
        "Eotaxin, an endogenous cognitive deteriorating chemokine (Ecdc), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in Schizophrenia patients",
        "The scale for the assessment of negative symptoms (SANS): Conceptual and theoretical foundations",
        "The positive and negative syndrome scale (PANSS) for Schizophrenia",
        "The brief psychiatric rating scale",
        "The assessment of anxiety states by rating",
        "A rating scale for depression",
        "A rating scale for fibromyalgia and chronic fatigue syndrome (The Fi-broFatigue scale)",
        "IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: Association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway",
        "Circulating antibodies to IDO/THO pathway metabolites in alzheimer's disease",
        "Controlling the false discovery rate: A practical and powerful approach to multiple testing",
        "Structural equation modeling with the Smart PLS",
        "Targeting IL-1 in depression",
        "Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta",
        "Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme",
        "Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells",
        "From airway inflammation to inflammatory bowel disease: Eo-taxin-1, a key regulator of intestinal inflammation",
        "IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy",
        "IL-13 induces eosinophil recruitment into the lung by an IL-5-and eotaxin-dependent mechanism",
        "Increased serum levels of CCL11/eotaxin in Schizophrenia",
        "Differences in eotaxin serum levels patients with recent onset and in chronic stable Schizophrenia: A clue for understanding accelerating aging profile",
        "Profiling inflammatory signatures of Schizophrenia: A cross-sectional and meta-analysis study",
        "Abnormalities in chemokine levels in schizophrenia and their clinical correlates",
        "The compensatory immune-regulatory reflex system (Cirs) in depression and bipolar disorder",
        "The Many Neuroprogressive Actions of Tryptophan Catabolites (TRY-CATs) that may be associated with the pathophysiology of neuroimmune disorders",
        "The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease",
        "Rapid transport of CCL11 across the blood-brain barrier: Regional variation and importance of blood cells",
        "Effects of facial nerve axotomy on Th2-and Th1-associated chemokine expression in the facial motor nucleus of wild-type and presymptomatic mSOD1 mice",
        "Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats",
        "Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease",
        "Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia-significance for activation of the kynurenine pathway",
        "Induction of indola-mine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-gamma?",
        "Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?",
        "Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia",
        "Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia",
        "Absence of IFN\u03b3 promotes hippocampal plasticity and enhances cognitive performance",
        "Inflammatory markers and their association with post stroke cognitive decline",
        "The Chemokine MIP-1\u03b1/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory",
        "Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide",
        "The ageing systemic milieu negatively regulates neurogenesis and cognitive function",
        "Negative symptoms and cognitive deficits: What is the nature of their relationship?",
        "The role of negative symptoms and cognitive dysfunction in schizophrenia outcome",
        "From prediction error to psychosis: Ketamine as a pharmacological model of delusions",
        "Explaining the symptoms of schizophrenia: Abnormalities in the awareness of action",
        "Executive functioning in schizophrenia",
        "Schizophrenia and quality of life: How important are symptoms and functioning?",
        "Quality of life in schizophrenic patients",
        "Stigmatization of schizophrenia as perceived by nurses, medical doctors, medical students and patients",
        "Name change for schizophrenia",
        "Targeting IL-1 in depression",
        "Tryptophan degradation in autoimmune diseases",
        "Eosinophils in autoimmune diseases",
        "Crucial roles of macrophages in the pathogenesis of autoimmune disease",
        "The role of aberrations in the immune-inflammatory reflex system (IRS) and the compensatory immune-regulatory reflex system (cirs) in different phenotypes of schizophrenia: The IRS-CIRS theory of schizophrenia",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory reflex system in antipsychotic naive first episode psychosis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Asahi Glass Foundation",
        "Chulalongkorn University"
    ]
}